Atlas Trials

Monitoring of Ceftolozane-Tazobactam Plasmatic Levels in Critical Patients

Clinical trial NCT04257812 · UNKNOWN

Trial details

NCT number
NCT04257812
Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status
UNKNOWN
Study type
OBSERVATIONAL
Serious Infection
Start date
2020-02-15
Primary completion
2021-03-15
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.